It is well known that in patients with severe renal insufficiency dietary protein restriction delays the appearance of uremic symptoms and prolongs survival. More recently, it was also postulated that protein restriction could attenuate the progression of chronic renal failure (1) . Indeed it became apparent in animal studies that early institution of a protein-restricted diet could delay the development of proteinuria and glomerulosclerosis. Thus, Hostetter (2) et al demonstrated in the remnant kidney model that protein restriction prevented the development of renal failure, which could be attributed to prevention of the development of glomerular hypertension and hyperfiltration. Consequently, it was suggested that these changes in glomerular hemodynamics that occurred to compensate for the loss of renal function, were ultimately harmful to the remaining nephrons. It was postulated that these secondary hemodynamic changes were a final common pathway for the progression of chronic renal failure (1) . Indeed, protein restriction could attenuate the progression in other experimental models of chronic renal insufficiency characterizerd by glomerular hyperfiltration, such as rats with diabetic nephropathy (3) and Fawn-hooded rats (4) . However, in rats with serum nephritis (5) and adriamycin- (6, 7) or puromycininduced nephrosis (8, 9) , models of renal failure not characterized by glomerular hyperfiltration, protein restriction also attenuated the progression of renal failure. This would suggest that protein restriction may ameliorate the course of chronic renal failure through other than hemodynamic effects. Heidland et al (10) recently reviewed other possible beneficial effects of dietary protein restriction on the course of chronic renal failure such as reduction of proteinuria with subsequently diminished mesangial protein overloading, decrease of reactive oxygen species, reduction of tubular hypermetabolism, growth factor and cytokines, ammonia and metabolic acidosis, and uremic toxins.
Several retrospective studies in patients also reported a slowing of the decline in renal function when patients adhered to low protein diets (11) (12) (13) (14) . In the present review we will focus on the results of randomized, prospective studies that investigated the effect of dietary protein restriction on the course of chronic renal failure. 0391-3988/304-05 $02.50/0
Non-diabetic renal failure
One of the first published prospective, randomized trials was that by Rosman et al (15) . In this study, 228 patients with various renal diseases were stratified for sex, age and degree of renal failure, and then randomly assigned to a protein-restricted or a control diet. Patients with moderate renal failure (creatinine clearance 31-60 ml/min/1.73 rn-) were prescribed a 0.6 g protein/kg body weight protein diet, and patients with severe renal failure (creatinine clearance 10-30 ml/min/1.73 rn') took a 0.4 g protein/kg body weight protein diet (supplemented with methionine if necessary). After 18 months the patients on a proteinrestricted diet had an attenuated decline in renal function measured as the reciprocal of median serum creatinine and creatinine clearance over time (15, 16) . Furthermore, fourteen patients who adhered to the control diet but only six patients in the protein-restricted diet groups reached end-stage renal failure. At longer follow-up, however, the results were less convincing (17) . Although after four years 25 patients on the control diet had progressed to endstage renal failure versus 14 patients in the protein-restricted diet (p<0.05), this could be entirely ascribed to the beneficial effect of protein restriction in the patients with severe renal failure. In the patients with moderate renal failure, no effect of the diet could be established (17) . When utilizing creatinine clearance over time to evaluate the effect of protein restriction, it appeared also that especially patients with severe renal failure benefited from the diet. A few years later, Ihle et al (18) also reported a beneficial effect of protein restriction. These investigators randomized 64 patients with severe renal failure (mean 51Cr-EDTA clearance 15 ml/min) to either a control diet or a proteinrestricted diet (0.4 g protein/kg body weight). After 18 months of follow up, the decline in GFR was retarded in the protein-restricted patients and nine of the 33 control patients and two of the 31 protein-restricted patients (p<0.05) reached end-stage renal failure. Thus, these investigators concluded that dietary protein restriction resulted in an attenuation of the decline in renal function of patients with severe renal insufficiency.
Two later studies shed doubt on the beneficial effect of protein restriction. In a multicentre study, Locatelli et al (19) randomized 456 patients with chronic renal failure and a creatinine clearance below 60 ml/min to a control protein diet (1.0 g/kg body weight) or a low protein diet (0.6 g/kg body weight). Patients were followed for two years or until their serum creatinine had doubled or dialysis was needed. After two years, 27 patients on the low protein diet and 42 control patients had reached one of these endpoints. This difference was not statistically significant (p<0.06). In addition, if changes in plasma creatinine, creatinine clearances or slopes of reciprocal serum creatinine over time were used to follow-up the course of renal function, no differences between the two groups could be found. In this study, however, compliance of the patients on a low protein diet was poor, patients in this group having a median protein overintake of 40%. Compliance of the control patients was good. The authors concluded that dietary protein restriction did not have additional beneficial effects over a 'normal' protein diet. Likewise, Williams et al (20) could not demonstrate a beneficial effect for protein restriction. These investigators randomized 95 patients with severe renal failure to either a 0.6 or a 0.8 g/kg body weight protein diet. After an average follow-up period of 19 ± 3 months, no difference in the rate of decline in creatinine clearance or serum creatinine over time could be demonstrated between the two groups. Thus, these authors concluded that protein restriction had no effect on the progression of renal failure.
In another, more recent Italian study (21) , 128 patients were randomly assigned to either a control diet or a low protein diet and followed for an average period of 27 months. At the end of the study the patients on a low protein diet had an estimated protein intake that was only 0.3 glkg less than the patients on the control diet. Nevertheless, there was a significant reduction in the number of patients having a 50% reduction in creatinine clearance over time in the low protein diet group (28.6%) compared to the control diet group (40%; p =0.038). In addition the initial level of proteinuria was shown to be an independent risk factor for progression of renal failure, as also reported by other investigators (22, 23) .
Recently, the results of the Modification of Diet in Renal Disease (MDRD) trial were presented (24) . In this large multicentre study patients with moderate renal failure (GFR between 25-55 ml/min) were randomized to a usual protein diet (1.3 g/kg body weight) or a low-protein diet (0.58 g/kg body weight). Patients with severe renal failure (GFR 25 ml/min) were randomized to a low protein diet (0.58 g/kg body weight) or a very low-protein diet (0.58 g/kg body weight) supplemented with a keto acid-amino acid mixture. After an average follow-up period of 2.2 years only a slight beneficial effect of protein restriction on the course of chronic renal failure could initials be demonstrated in patients with moderate renal failure. With severe renal failure no differences between the treatment groups were present. From this study several caveats exists, however, that might result in an underestimation of the effect of protein restriction. First, the patients with moderate renal failure manifested throughout the first four months of the study a steeper decline in GFR than those on the control diet. It is well known that a reduction in dietary protein intake does reduce GFR through hemodynamic mechanisms not only in healthy subjects (25) but also in patients with renal insufficiency (26) . Thus, the initial fall in GFR observed in the first four months of the MDRD trial should be attributed to hemodynamic adaptations of the kidneys to the dietary protein restriction and for a thorough comparison of the two groups the analysis should exclude the first four months of the study. Indeed if the initial four months were excluded from the analysis of the MDRD trial, the decline in GFR was attenuated compared to control subjects (24) . At the end of the study period, however, the GFR of the two groups did not differ. The authors concluded that a longer follow-up period was needed to reach statistical difference. If on the other hand the patients on the low protein diet would have been given a normal protein diet, their GFR would increase in analogy to observations by Bilo et al (26) . Therefore, the similar GFR of the protein-restricted patients in fact implies conservation of GFR. The second caveat is that the study lacked a patient group with severe renal failure that adhered to a control diet. Thus, it is very well feasible that reducing protein intake in patients with severe renal insufficiency does have a beneficial effect on the course of chronic renal failure.
In a secondary analysis of the MDRD trial for the patients with severe renal insufficiency, Levey et al (27) were able to demonstrate in both the low and very low protein diet group that the actual protein intake correlated with the rate of decline in GFR i.e, the higher the protein intake the faster the deterioration of renal function. Thus, also in patients with severe renal function the rate of progression was related to dietary protein intake. In fact it was calculated that for every 0.2 g/kg body weight protein reduction, a 1.15 ml/min/year slower decline in GFR was obtained, which was equivalent to a 29% reduction in the rate of GFR decline. The latter would imply a 41% prolongation of the time before end-stage renal failure is reached. Thus, it was concluded that dietary protein restriction has a beneficial effect on the progression of both moderate and severe chronic renal failure. Addition of a mixture of keto acids and amino acids did not have an additional beneficial effect.
A third caveat is the fact that in MDRD trial patients were treated with anti-hypertensive agents, preferably angiotensin converting enzyme inhibitors, to achieve usual blood pressure or a low blood pressure. In such a setting of minimal hemodynamically-mediated renal injury, the benefit of protein restriction is hard to demonstrate. On the other hand this implies that aggressive treatment of hypertension, probably to values below the usually accepted blood pressure goals, might be more useful to retard the progression of chronic renal failure than dietary protein restriction only.
So far, two meta-analysis of randomized prospective studies on the subject of dietary protein intake and the progression of chronic renal failure have been published. Fouque et al (28) included in their meta-analysis 890 patients with mild to severe chronic renal insufficiency. In patients on a control diet, 95 patients reached end-stage renal disease for which renal replacement therapy was needed versus 61 patients on a protein-restricted diet. This was reflected in an odds ratio of low protein to control of 0.54 with a 95% confidence interval of 0.37 to 0.79. The authors concluded, however, that it could not be discerned whether the institution of a protein-restricted diet had postponed the need for dialysis through a retardation of the rate of progression of chronic renal failure or merely through a delay in the development of uremic symptoms. More recently, Pedrini et al (29) reported their meta-analysis in which they had included 1413 patients. These investigators demonstrated that dietary protein restriction significantly reduced the risk for renal failure or death with a relative risk of 0.67 (95% confidence interval 0.50 to 0.89) in the low protein diet patients. Thus it was concluded that protein restriction appeared to be an effective measure to slow down the rate progression in patients with non-diabetic chronic renal failure.
Diabetic renal failure
Soon after studies in diabetic rats that demonstrated a beneficial effect of protein restriction on the development of renal failure, studies on this subject in human diabetic 306 renal disease were reported. Barsotti et al (30) prospectively followed for an average of 17.4 ± 5.8 months eight patients with insulin-dependent diabetes mellitus and severe renal failure who had been switched from a usual diet to a low protein diet. Dietary protein restriction resulted in a significant reduction of proteinuria and a decline in the rate of progression. In a similar study design, Walker et al (31) followed 19 insulin-dependent patients with diabetic nephropathy for 29 months on a usual protein diet (1.13 g/kg), and for 33 months on a low protein diet (0.67 g/kg). These investigators also demonstrated that dietary protein restriction reduced albuminuria and the rate of progression. So far, we are aware of only four randomized, prospective trials in insulin-dependent diabetic patients with diabetic nephropathy that compare a patient group on a normal protein diet with a group on a protein-restricted diet (32) (33) (34) (35) . In two studies patients had been followed up to six months (32, 33) , but in the other two studies the follow-up period exceeded two years (34, 35) . The number of patients was relatively small. Nevertheless, in all four studies it was concluded that patients that adhered to a low protein diet had a lower level of proteinuria and a slower rate of progression of renal failure than patients on a normal protein diet.
In their meta-analysis, Pedrini et al (29) included five of the above mentioned, prospective studies (the study by Raal et al (33) was not included). They concluded that dietary protein restriction reduced the risk for a rise in albuminuria and progression of renal failure with a relative risk of 0.56 (95% confidence interval 0.40 to 0.77). Because no differences between mean arterial blood pressure or glycosylated hemoglobin levels could be discerned between the patients on the low protein diets or the control diets, it was concluded that the beneficial effect of dietary protein restriction was not mediated through effects on blood pressure or glycemic control.
Although the numbers of patients in the currently available studies are small, it seems justifiable to start in patients with insulin-dependent diabetes mellitus and nephropathy early on a low protein diet in order to try to retard the progression of chronic renal failure. No such data for patients with non-insulin-dependent diabetes are available. However, because in both types of diabetes mellitus similar mechanisms may be involved in the development of diabetic nephropathy, low protein diets may be beneficial also in non-insulin-dependent patients with nephropathy.
ter Wee and Danker Summary
Altogether there seems to be increasing evidence that dietary protein restriction may retard progression of chronic renal failure. So far it is not clear whether total protein intake has to be reduced or whether it is only necessary to reduce specific sources of protein like red meat. It is well known that for instance vegetable proteins hardly affect GFR and that vegeratians can have low creatinine clearances (25) . Also unsolved is the question whether all renal diseases benefit equally well from protein restriction, as their is some evidence that, apart from patients with diabetic renal failure, patients with chronic glomerulonephritis do benefit from protein restriction (17) whereas patients with polycystic kidney disease hardly do (19) . In addition, there may also be sex differences (17) . It is also not known at what stage of renal disease a low protein diet should be
